Atropine suppression test
Term · Oncology and biomedicine · MLC-T-ONC-000798
A test used to help find out if secretion of pancreatic polypeptide (a protein released by the pancreas) is normal or caused by a tumor. A drug called atropine sulfate is injected into the patient’s vein and level of pancreatic polypeptide in the blood is measured. If there is a tumor, the injection will not change the level of pancreatic polypeptide. If there is no tumor, the level of pancreatic polypeptide will drop.
| Identifier | MLC-T-ONC-000798 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000798",
"term": "Atropine suppression test",
"field": "Oncology and biomedicine",
"definition": "A test used to help find out if secretion of pancreatic polypeptide (a protein released by the pancreas) is normal or caused by a tumor. A drug called atropine sulfate is injected into the patient’s vein and level of pancreatic polypeptide in the blood is measured. If there is a tumor, the injection will not change the level of pancreatic polypeptide. If there is no tumor, the level of pancreatic polypeptide will drop.",
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/atropine-suppression-test/"
}
Record 2,577 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.